eTMF market to grow sizably over next three years, ISR reports

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/ArtemSam)
(Image: iStock/ArtemSam)
The adoption of eTMF solutions is accelerating – with more than 50% of investigative sites expected to have access to a sponsor/CRO eTMF application within three years.

This figure is according to a recent report​ published by Industry Standard Research (ISR), which assessed eTMF (electronic trial master file) application access to be around 20% today.

Andrew Schafer, President, Industry Standard Research (ISR) said the driving demand is “simply an evolution​” of pharmaceutical and service providers to web-based applications.

Schafer compared the shift in the market to the adoption curve of other eClinical technologies, such as EDC, eCOA, ePRO, and IRT/IVR.

Based on those services and what we have witnessed, early and high market penetration is key to long-term success in these markets​,” he told us. “There are certainly clear leadership positions being established, but there is also a segment of providers that can easily climb into the top share positions​.”

According to the report, survey respondents – including both pharma and CROs – recently interacted with two eTMF systems.

It will be interesting, if the data hold and sites gain more access to CRO/sponsor eTMF systems, then sites will quickly be ‘burdened’ with having to navigate many more eTMF systems, just as they do with EDC systems today​,” said Schafer.

Related topics: Markets & Regulations, Data management

Related news

Show more

Related products

show more

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us


View more